In melanoma (Hehlgans and Männel, 2001), colorectal cancer (Maker et al., 2015; Qiao et al., 2017), and prostate cancer (Yan et al., 2015), a higher level of LIGHT expression was associated with a better prognosis. Here, TNFSF14 is linked to colorectal cancer.